In this study, we analyzed the proportion of Th17 cells and the expression of IL-17 and RORγt2 in NSCLC patients by flow cytometry, real-time quantitative PCR, and ELISA. The gene discussed is IL17A; the disease is non-small cell lung carcinoma.